Table 5.

Clinical outcomes of neonates born from women infected by SARS-CoV-2.

Study	New-borns, n	Pre-term, n (%)	Mean (range) birthweight, g	Apgar score 1 min, range	Apgar score 5 min, range	Complication*, n (%)	SARS-CoV2 RNA	Death, n (%)	*
Li Y., et al. [2]	1	0	–	–	–	0 (0.0)	0	0	–
Chen H., et al. [3]	9	4 (44.4)	3011 (1880−3820)	8−9	9−10	2 (22.2)	0 (0.0)	0 (0.0)	Low birthweight 2
Fan C., et al. [4]	2	0 (0.0)	3145 (2890−3400)	9	10	2 (100)	0 (0.0)	0 (0.0)	Fever and abdominal distension and lymphopenia 1; pneumonia and lymphopenia 1
Chen Y., et al. [5]	4	0 (0.0)	3000 (3050−3800)	7−8	8−9	2 (50.0)	0/3 (0.0)	0 (0.0)	Skin rash 2; Oedema 1; Transient tachypnoea of the newborn 1.
Zhu H., et al. [6]	10	6 (60.0)	2423 (1520−3800)	7−10	8−10	9 (90.0)	0 (0.0)	1 (10.0)	shortness of breath 6; fever 2; Rapid heart rate 1; Gastrointestinal symptoms 4; Infections 4; neonatal respiratory distress syndrome (NRDS) 2; pneumothorax 1
Zhang L., et al. [7]	16	1 (6.3)	3139 (2300−3750)	–	–	3 (18.8)	0/10 (0.0)	0 (0.0)	Pneumoniae 3
Liu W., et al. [8]	3	0 (0.0)	3390 (3250−3670)	8	9	2 (66.7)	0 (0.0)	0 (0.0)	Meconium Stained Amniotic Fluid (MSAF) 1; Slight decreased responsiveness and muscle tension 1.
Wang X., et al. [9]	1	1	1830	9	10	0 (0.0)	0 (0.0)	0 (0.0)	–
Liu D., et al. [10]	11	–	–	8	9	0 (0.0)	0 (0.0)	0 (0.0)	–
Liu Y., et al. [15]	10	6 (60.0)	–	–	–	–	–	1 (10.0)	–
Yu N., et al. [16]	7	0 (0.0)	3264 (3000−3500)	8−9	9−10	1 (14.3)	1/3 (33.3)	0 (0.0)	SARS-CoV2 positivity with mild pulmonary infection.
Zeng L., et al. [17]	33	4 (12.1)	–	–	–	No individual data	3 (9.1)	0 (0.0)	Fever 2, SARS-Cov2 pneumoniae 3; Shortness of breath 4; Respiratory distress syndrome 4; Cyanosis 3; Feeding intolerance 3
Dong L., et al. [18]	1	0	3120	9	10	1	0 (0.0)	0 (0.0)	Abnormal cytokine test results 2 h after birth